| Initial investigations: | |
| CT scan | Stable periventricular white matter changes |
| Electroencephalogram | A moderate nonspecific generalized cerebral dysfunction. There were no epileptiform discharges or seizures recorded. |
| MRI brain | Increased demyelinating plaques since prior scan in 2015 |
| MRI cervical spine | Numerous new demyelinating plaques throughout the cervical spine |
| MRI upper extremities | There is bilateral symmetric muscle edema without fatty infiltration/atrophy. |
| Upper limb arterial doppler | Normal left arm pressures and waveforms. |
| Total Lymphocyte | 8400/mcl |
| ESR | 12 |
| CRP | 6 mg/l |
| Urine toxicology | Cannabinoids positive |
| CSF analysis | Elevated protein and WBC count of 128 (53% PMNs, 42% lymphocytes). Lyme CSF, CSF VDRL were negative. CSF ACE levels within normal limits. |
| CSF Myelin basic protein | 67.90 ng/mL |
| Lyme antibodies, HIV antibodies | Negative |
| Serum Vit B1, Vitamin B12, aldolase, serum copper, Serum immunoglobulins | Within normal limits |
| Immunological work-up | Negative |
| Blood, urine and sputum cultures | Negative |
|
| |
| Cardiac work-up | |
| ECHO (Day 4) | LVEF 50%. Moderate basal hypokinesis with preserved to hyper-contractile apical function. Normal RV systolic function, as shown in Figure 2(a). |
| ECHO (Day 14) | EF 55% - 60%, mildly hypokinetic segments in basal region (improved from previous study), Figure 2(b). |
| High sensitivity troponin | 34 pg/ml à 37 pg/ml à 47 pg/ml |